What is Global Transcatheter Aortic Valve Implantation (TAVI) Market?
The Global Transcatheter Aortic Valve Implantation (TAVI) Market is a rapidly evolving sector that focuses on the development and distribution of TAVI devices. These devices are used in a minimally invasive procedure to replace the aortic valve in patients suffering from aortic stenosis, a condition characterized by the narrowing of the aortic valve opening. The global TAVI market is a dynamic one, with constant advancements in technology and medical procedures contributing to its growth. The market is driven by the increasing prevalence of aortic stenosis, the rising geriatric population, and the growing preference for minimally invasive surgeries. The TAVI market is also influenced by various factors such as regulatory policies, the economic environment, and the level of research and development in the medical field.
Transfemoral Approach, Transapical Approach, Others in the Global Transcatheter Aortic Valve Implantation (TAVI) Market:
The Global Transcatheter Aortic Valve Implantation (TAVI) Market is segmented based on the approach used for the procedure. The three main approaches are the Transfemoral Approach, the Transapical Approach, and others. The Transfemoral Approach is the most common and involves inserting the TAVI device through the femoral artery in the leg. This approach is less invasive and has a shorter recovery time compared to traditional open-heart surgery. The Transapical Approach involves inserting the TAVI device through a small incision in the chest and directly into the heart. This approach is typically used for patients who cannot undergo the Transfemoral Approach due to issues with their femoral artery. Other approaches include the Transaortic and Subclavian approaches. Each approach has its own set of advantages and disadvantages, and the choice of approach depends on the patient's specific condition and overall health.
Aortic Stenosis, Aortic Regurgitation, Others in the Global Transcatheter Aortic Valve Implantation (TAVI) Market:
The Global Transcatheter Aortic Valve Implantation (TAVI) Market finds its application in various areas such as Aortic Stenosis, Aortic Regurgitation, and others. Aortic Stenosis is a condition where the aortic valve becomes narrow, restricting blood flow from the heart to the rest of the body. TAVI is a revolutionary procedure that offers a less invasive alternative to open-heart surgery for treating this condition. Aortic Regurgitation is a condition where the aortic valve does not close properly, causing blood to leak back into the heart. TAVI can also be used to treat this condition, providing a safer and more effective treatment option for patients. Other applications of TAVI include treating congenital heart defects and other heart valve diseases.
Global Transcatheter Aortic Valve Implantation (TAVI) Market Outlook:
The future of the Global Transcatheter Aortic Valve Implantation (TAVI) Market looks promising. In 2023, the market was valued at US$ 4008.6 million and it is projected to reach US$ 5415.8 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period from 2024 to 2030. The largest segment of the market is the Transfemoral Approach, which accounts for over 80% of the market. This dominance can be attributed to the advantages of the Transfemoral Approach, such as its less invasive nature and shorter recovery time. The market's growth is expected to be driven by the increasing prevalence of aortic valve diseases and the growing preference for minimally invasive procedures.
| Report Metric | Details |
| Report Name | Transcatheter Aortic Valve Implantation (TAVI) Market |
| Accounted market size in 2023 | US$ 4008.6 million |
| Forecasted market size in 2030 | US$ 5415.8 million |
| CAGR | 4.3% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
